ursolic acid has been researched along with Adenocarcinoma, Basal Cell in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Gubernator, J; Jaromin, A; Markowski, A; Migdał, P; Olczak, E; Pawlik, K; Zaremba-Czogalla, M; Zygmunt, A | 1 |
| Gao, Y; Lin, S; Song, G; Yuan, Y | 1 |
| Aligiannis, N; Kassi, E; Moutsatsou, P; Papoutsi, Z; Pratsinis, H; Sourlingas, TG; Spiliotaki, M | 1 |
| Chen, Q; Chen, WR; Li, Y; Xing, D | 1 |
| Jadranin, M; Juranić, ZD; Konić-Ristić, A; Menković, N; Savikin, K; Stanojković, TP; Zdunić, G | 1 |
| Craft, CC; Hurta, RA; Kondo, M; MacKinnon, SL; Matchett, MD; Neto, CC | 1 |
| Bist, P; Hui, KM; Kumar, AP; Lim, LH; Manu, KA; Ong, TH; Ramachandran, L; Sethi, G; Shanmugam, MK; Surana, R | 1 |
| Kim, ST; Kim, SY; Koh, SJ; Nam, WS; Park, JW; Park, KM; Tak, JK | 1 |
| Ho, PC; Hui, KM; Kumar, AP; Lun, CK; Ong, TH; Sethi, G; Shanmugam, MK; Wong, PT | 1 |
9 other study(ies) available for ursolic acid and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Design and Development of a New Type of Hybrid PLGA/Lipid Nanoparticle as an Ursolic Acid Delivery System against Pancreatic Ductal Adenocarcinoma Cells.
Topics: Adenocarcinoma; Humans; Lactic Acid; Liposomes; Nanoparticles; Pancreatic Neoplasms; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Triterpenes; Ursolic Acid | 2022 |
Ursolic acid and oleanolic acid from Eriobotrya fragrans inhibited the viability of A549 cells.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Line, Tumor; Eriobotrya; Humans; Oleanolic Acid; Triterpenes; Ursolic Acid | 2015 |
Ursolic acid triggers apoptosis and Bcl-2 downregulation in MCF-7 breast cancer cells.
Topics: Active Transport, Cell Nucleus; Adenocarcinoma; Antineoplastic Agents; Apoptosis; Binding, Competitive; Breast Neoplasms; Cell Line, Tumor; Dexamethasone; Down-Regulation; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; Genes, bcl-2; HeLa Cells; Humans; Mifepristone; Neoplasm Proteins; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Receptors, Glucocorticoid; Transcription Factor AP-1; Transcription, Genetic; Triamcinolone; Triterpenes; Ursolic Acid | 2009 |
Enhancement of chemotherapeutic agent-induced apoptosis by inhibition of NF-kappaB using ursolic acid.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Blotting, Western; Caspase 8; Cell Proliferation; Cells, Cultured; Cisplatin; Cytochromes c; Drug Synergism; Fas Ligand Protein; fas Receptor; Female; Flow Cytometry; Humans; Liver; Luciferases; Lung; Lung Neoplasms; Mice; NF-kappa B; Protein Transport; RNA, Small Interfering; Signal Transduction; Triterpenes; Ursolic Acid; Uterine Cervical Neoplasms | 2010 |
Cytotoxic and cell cycle effects induced by two herbal extracts on human cervix carcinoma and human breast cancer cell lines.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cinnamates; Depsides; Female; HeLa Cells; Humans; Inhibitory Concentration 50; Magnoliopsida; Phenols; Phytotherapy; Plant Extracts; Rosmarinic Acid; Tannins; Triterpenes; Ursolic Acid; Uterine Cervical Neoplasms | 2010 |
Ursolic acid and its esters: occurrence in cranberries and other Vaccinium fruit and effects on matrix metalloproteinase activity in DU145 prostate tumor cells.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Chromatography, High Pressure Liquid; Esters; Fruit; Humans; Male; Mass Spectrometry; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Phytotherapy; Plant Extracts; Prostatic Neoplasms; Triterpenes; Ursolic Acid; Vaccinium; Vaccinium macrocarpon | 2011 |
Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Movement; Chemokine CXCL12; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Transgenic; Neoplasm Metastasis; NF-kappa B; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Receptors, CXCR4; Signal Transduction; Triterpenes; Ursolic Acid | 2011 |
Sensitization of ionizing radiation-induced apoptosis by ursolic acid.
Topics: Adenocarcinoma; Animals; Apoptosis; Cell Line, Tumor; Chemoradiotherapy; Colonic Neoplasms; Combined Modality Therapy; DNA Fragmentation; DNA, Neoplasm; Drug Screening Assays, Antitumor; Lipid Peroxidation; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Oxidation-Reduction; Prostatic Neoplasms; Radiation-Sensitizing Agents; Triterpenes; Ursolic Acid | 2012 |
Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Blotting, Western; Caspase 3; Cyclin D1; Cyclooxygenase 2; DNA Primers; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation, Neoplastic; Immunohistochemistry; Kaplan-Meier Estimate; Male; Mice; Mice, Transgenic; Prostatic Neoplasms; Signal Transduction; Spectrophotometry; Survival Analysis; Triterpenes; Ursolic Acid | 2012 |